Lilly 4Q Revenues: $4.2 billion (+9%) 4Q Earnings: $132.3 million (earnings were $700.6 million 4Q2005) FY Revenues: $15.7 billion (+7%) FY Earnings: $2.7 billion (+35%) Comments: In the quarter, Alimta, Byetta, Cialis, Cymbalta, Forteo, Strattera, Symbyax, Xigris and Yentreve, collectively grew 41% to $1.1 billion and accounted for 26% of total sales, up from 20% of sales in 4Q2005. For the year these product sales grew 47% to $3.8 billion and accounted for 24% of total s...